nuoxin (cisplatin injection)-比较正规的买球软件

中

about us
- founded in 1995, hansoh is a leading r&d-driven pharmaceutical company in china.
- founded in 1995, hansoh is a leading r&d-driven pharmaceutical company in china.
- founded in 1995, hansoh is a leading r&d-driven pharmaceutical company in china.
- founded in 1995, hansoh is a leading r&d-driven pharmaceutical company in china.
- founded in 1995, hansoh is a leading r&d-driven pharmaceutical company in china.
news
- company news
- media focus
- with the objective of 'creating excellence in china's pharmaceuticals and add momentum to "made in china"',hansoh endeavors to make its own contribution to the “healthy china 2030” master plan.
- with the objective of 'creating excellence in china's pharmaceuticals and add momentum to "made in china"',hansoh endeavors to make its own contribution to the “healthy china 2030” master plan.
products
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
r&d
- hansoh has been holding on to the strategy of technology and innovation, and established r&d centers located in lianyungang and shanghai.
- hansoh has been holding on to the strategy of technology and innovation, and established r&d centers located in lianyungang and shanghai.
- hansoh has been holding on to the strategy of technology and innovation, and established r&d centers located in lianyungang and shanghai.
- hansoh has been holding on to the strategy of technology and innovation, and established r&d centers located in lianyungang and shanghai.
services
- hansoh pursuits the philosophy of “professional marketing of medical products for benefits of all doctors and patients” to actively carry out national policies and establish innovate marketing systems
- hansoh pursuits the philosophy of “professional marketing of medical products for benefits of all doctors and patients” to actively carry out national policies and establish innovate marketing systems
- hansoh pursuits the philosophy of “professional marketing of medical products for benefits of all doctors and patients” to actively carry out national policies and establish innovate
contact us
- hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.
- hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.
- hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.
- hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.

nuoxin (cisplatin injection)

cisplatin injection

english name: cisplatin injection

chinese pinyin: shunbo zhusheye

the main component of this product is cisplatin.

chemical name: cis-dichlorodiammineplatinum

/en/upload/images/2018/08/28/a2bd53f955e04c238ae3b6e61dcaa755.png

【name】	common name：cisplatin injection brand name: nuoxin english name: cisplatin injection chinese pinyin: shunbo zhusheye
【ingredient】	the main component of this product is cisplatin. chemical name: cis-dichlorodiammineplatinum chemical structure: molecular formula: cl₂h₆n₂pt molecular weight: 300.05 excipients: sodium chloride, polyethylene glycol 400.
【description】	this product is a yellowish green to pale yellow clear liquid with slightly viscidity.
【indications】	small cell and non-small cell lung cancer, testicular cancer, ovarian cancer, cervical cancer, endometrial cancer, prostate cancer, bladder cancer, melanoma, sarcoma, head and neck tumors, various squamous cell carcinomas and malignant lymphomas.
【strength】	6ml:30mg。
【dosage and administration】	cisplatin can only be administered intravenously, intra-arterially or intraperitoneally. it is usually administered by intravenous drip. adequate hydration treatment is necessary 2 to 16 hours before administration and at least 6 hours after administration. this product should be diluted with saline or 5% dextrose solution and then intravenously instilled. the dose depends on the effect of chemotherapy and individual response. the following dosages are for reference (for adults and children): the course of treatment is based on clinical efficacy and is repeated once every 3 to 4 weeks. this product can be used either in combination therapy with other anticancer drugs, or be used alone. when used in combination therapy, the dosage should be adjusted as appropriate. note: please refer to the product manual for details.